trxadehealth.com - Multiplikator nilai perusahaan marang pendapatan MEDS

The EV/Revenue multiple confirms the resilience of TRxADE HEALTH, Inc. (MEDS) due to network effects and high software switching costs. The b2b marketplace for pharmacies serves as a steady cash generator, while the greening of supply chains minimizes drug losses. The current 3345.05 determines the metric's magnitude, helping investors identify asset overheating in real time and avoid buying at the peak.
TRxADE - rincian analitis lan metrik utama (MEDS)

Pharmacy confidence in the transparent digital marketplace of TRxADE HEALTH (MEDS) ensures a stable revenue stream, which serves as the basis for calculating this metric. An analysis of the EV/Sales ratio allows for an assessment of the total business value, including debt, relative to its sales, stripping speculative noise from the market price and revealing either a fundamental undervaluation of the asset or signs of overheating.